Immunization

Childrens' DTP Vaccine Is In Short Supply

Published in Medical Letter on the CDC and FDA, January 27th, 2002

The national shortage of the vaccine that protects children against tetanus, diphtheria and whooping cough will continue through at least the middle of the year, the U.S. Centers for Disease Control and Prevention (CDC) says.

The CDC did not estimate when the shortage of DTP might end. It has been in short supply since 2000, when two manufacturers quit making it, leaving Aventis Pasteur and GlaxoSmithKline as the only U.S. suppliers.

The shot is typically given to children in a series of five doses - beginning during the child's first six months and ending at age four to six.

During the shortage, the CDC said, doctors can defer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-01-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry